Phase II Study of Weekly Paclitaxel by 1-HR Infusion plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: A trial of the ECOG-ACRIN Cancer Research Group (E1898)

INTRODUCTION: This multi-center phase II study assessed the combination of estramustine and weekly paclitaxel with metastatic castrate resistant prostate cancer (CRPC). METHODS: We enrolled 77 patients who had no prior chemotherapy for CRPC between 1998 and 2000. 74 were eligible. Each 8-week cycle...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Genitourin Cancer
Main Authors: Wong, Yu-Ning, Manola, Judith, Hudes, Gary R., Roth, Bruce J., Moul, Judd W., Barsevick, Andrea M., Scher, Richard M., Volk, Michael J., Vaughn, David J., Williams, Stephen D, Fisch, Michael J., Cella, David, Carducci, Michael A, Wilding, George
Format: Artigo
Sprog:Inglês
Udgivet: 2017
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5975965/
https://ncbi.nlm.nih.gov/pubmed/29173976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2017.10.001
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker